Tornier refiles its U.S. anti-trust registration, effectively extending the waiting period on its pending, $3.3 billion merger with Wright Medical until nearly the end of the month.
Avinger files for a $69 million initial public offering, closing out a year of feverish medical device IPO activity.
Avinger closed out a feverish medtech IPO season with by registering for a $69 million initial public offering in the waning days of 2014.
Redwood City, Calif.-based Avinger, which makes a family of vascular catheters aimed at the peripheral vascular market, filed Dec. 30 with the FDA for the offering. The company was founded in 2007.
The FDA approves the use of Aethlon Medical's Hemopurifier in treating Ebola patients.
A toughening of Catholic medical directives could include enforcing a ban on tubal ligations.
The U.S. Conference of Catholic Bishops, shown in New Orleans in June, voted in November to tighten its rules on partnerships and collaborations between Catholic and non-Catholic health care providers. (Gerald Herbert/AP Photo)
by Nina Martin, ProPublica
Stryker says it acquired the U.K.'s CHG Hospital Beds for an undisclosed amount.
Stryker (NYSE:SYK), as expected, opened 2015 with the acquisition of a British company, just not the 1 most anticipated by observers.
Check-Cap says it plans to raise approximately $27 million with a $15 million initial public offering and a $12 million private placement.
Check-Cap announced plans to raise approximately $27 million with a $15 million initial public offering and a $12 million private placement, saying it will use the proceeds to develop its ingestible low-dose X-ray imaging capsule.
Osiris Therapeutics strikes an exclusive marketing deal with Stryker for its Bio4 bone-allograft product.
Osiris Therapeutics said it struck an exclusive marketing deal with Stryker (NYSE:SYK) for its Bio4 bone allograft.
